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Action Spectrum Analysis of UVR Genotoxicity for
Skin: The Border Wavelengths between UVA and
UVB Can Bring Serious Mutation Loads to Skin
Hironobu Ikehata1, Shoichi Higashi2, Shingo Nakamura1,6, Yasukazu Daigaku3,7, Yoshiya Furusawa4,
Yasuhiro Kamei2, Masakatsu Watanabe2,8, Kazuo Yamamoto3, Kotaro Hieda5, Nobuo Munakata5 and
Tetsuya Ono1,6
UVR causes erythema, which has been used as a standardized index to evaluate the risk of UVR for human skin.
However, the genotoxic significance of erythema has not been elucidated clearly. Here, we characterized the
wavelength dependence of the genotoxic and erythematic effects of UVR for the skin by analyzing the induction
kinetics of mutation and inflammation in mouse skin using lacZ-transgenic mice and monochromatic UVR
sources. We determined their action spectra and found a close correlation between erythema and an epidermis-
specific antigenotoxic response, mutation induction suppression (MIS), which suppressed the mutant frequen-
cies (MFs) to a constant plateau level only 2–3-fold higher than the background MF at the cost of apoptotic cell
death, suggesting that erythema may represent the threshold beyond which the antigenotoxic but tissue-
destructive MIS response commences. However, we unexpectedly found that MIS attenuates remarkably at the
border wavelengths between UVA and UVB around 315nm, elevating the MF plateaus up to levels B40-fold
higher than the background level. Thus, these border wavelengths can bring heavier mutation loads to the skin
than the otherwise more mutagenic and erythematic shorter wavelengths, suggesting that erythema-based UVR
risk evaluation should be reconsidered.
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INTRODUCTION
Exposure to environmental UVR, such as solar UVR, poses a
risk because of its potent genotoxicity for the skin. Although
UVR genotoxicity is known to depend on the wavelength
(Setlow, 1974), indicators of genotoxicity whose wavelength
dependency was determined have not been sufficiently
utilized for estimating the risk of UVR for the skin, partly
because most of them were not determined directly in the skin
genome (Setlow, 1974; Enninga et al., 1986; Jones et al.,
1987; Tyrell and Pidoux, 1987; Kielbassa et al., 1997;
Munakata et al., 2000), and partly because quantification of
these indicators in the skin is laborious, expensive, and/or
invasive (Freeman et al., 1989; de Gruijl et al., 1993; Young
et al., 1998). Instead, the UVR risk for human skin has been
estimated using the action spectrum of erythema (McKinlay
and Diffey, 1987), an empirical indicator easily detectable
on UVR-exposed skin. Erythema is an inflammatory response
in human skin and has been thought to indicate over-
exposure to the sun. However, the relationship between
erythema and UVR genotoxicity has not been elucidated,
and its use as a surrogate indicator of UVR-induced
genotoxicity has not been justified sufficiently, although a
close similarity in the action spectra was reported between
erythema and UVR-specific DNA damage formation in human
skin (Young et al., 1998).
UVR exerts its genotoxicity by providing the skin genome
with the photochemical energy to produce specific DNA
damage (Pfeifer, 1997), leading to genomic anomalies such
as mutations (Ikehata and Ono, 2011) that can cause skin
cancer (Wikonkal and Brash, 1999). Sunlight UVR
(wavelength 295–400 nm) consists of UVA (315–400 nm)
and a part of UVB (280–315 nm). The UVB component has
been thought to be a major contributor to the induction of
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human skin cancers (Setlow, 1974; de Gruijl and van der
Leun, 1994). We previously studied mutation induction in
mouse skin after noon sunlight exposure in summer and
compared it with UVB lamps that emit wavelengths shorter
than sunlight UVR (Ikehata and Ono, 2002; Ikehata et al.,
2004). The two UVR sources showed similar dose–response
kinetics of mutation induction in the epidermis, with a nearly
linear initial increase in mutant frequency (MF) followed by a
plateau above a certain UVR dose, which was a response we
termed ‘‘mutation induction suppression (MIS)’’ in a subse-
quent study (Ikehata et al., 2010). The MIS response is a skin-
specific antigenotoxic response we identified firstly with UVB
lamps (Ikehata and Ono, 2002) and later with other UVR
sources (Ikehata et al., 2004, 2008). However, the plateau MFs
observed after sunlight exposure were twice or more higher
than those induced with the UVB lamps, which was surprising
because UVR genotoxicity has been thought to strengthen as
the wavelength becomes shorter in the UVB region (Setlow,
1974; Jones et al., 1987; Tyrell and Pidoux, 1987). This
remarkable observation led us to determine the action
spectrum (the wavelength dependence of an effect per dose)
of UVR genotoxicity for the skin to clarify the cause of the high
mutation loads after sunlight exposure. Although many action
spectra for the genotoxic effects of UVR have been published
(Setlow, 1974; Woodcock and Magnus, 1976; Enninga et al.,
1986; Jones et al., 1987; Tyrell and Pidoux, 1987; Freeman
et al., 1989; de Gruijl et al., 1993; Kielbassa et al., 1997;
Young et al., 1998; Munakata et al., 2000; Aoki et al., 2004),
none of them were directly constructed for mutation induction
in the skin. We previously established a UVR-induced
mutation assay system using transgenic mice (Ikehata and
Ono, 2002), which enabled us to determine the action spectra
of UVR mutagenesis directly in the skin. This study using skin
also enabled us to examine UVR-induced inflammation, the
mouse counterpart of human erythema, and to compare the
genotoxicity and skin inflammation induced by UVR.
RESULTS
UVR dose–response kinetics of mutation induction in skin
The dose–response kinetics of mutation induction in the
epidermis and dermis of mouse skin was examined at 14
wavelength points in the range of 260–364 nm by irradiation
with high-intensity monochromatic UVR generated by the
large monochromator (Watanabe et al., 1982) or 364-nm laser
source (Ikehata et al., 2008) of the National Institute for Basic
Biology, Japan (Supplementary Figures S1 and S2 online). The
result at 300 nm is shown schematically as a representative
response pattern in Figure 1a. In the lower dose range, MFs
increased linearly in a dose-dependent manner in both the
epidermis (red line) and dermis (cyan) with a steeper slope
in the former at all the wavelengths examined (see
Supplementary Figure S1 online). The initial slopes of the
MF increases were defined as an index of mutagenicity. In the
epidermis, the MIS response was remarkable: the MF increase
leveled off rather abruptly and nearly completely above a
certain dose (blue line). MIS is characterized by the minimum
dose inducing the response where the MF increase starts to
level off (x: minimum MIS dose (MMISD)) and the MF level at
which the increase becomes a plateau (y: plateau MF). MIS
was observed at all the wavelengths examined except 334 nm
(see Supplementary Figure S1 online), where the exposure
time to induce MIS was too long for mice to tolerate because
of the limited monochromator output. The lowest dose that
induced skin inflammation macroscopically (green arrow-
head), manifested as edema, subsequent reddening and
desquamation, was also scored as the minimum inflammation
dose (MID).
Action spectra of UVR genotoxicity in the skin
On the basis of all of the dose–response kinetics data
(Supplementary Table S1 online), a set of action spectra was
generated (Supplementary Table S2 online). At 334 nm, the
values at 600 kJ m2, the highest dose examined, were
tentatively used for the MMISD and plateau MF. The action
spectra of mutagenicity, which were constructed with the
initial slopes of the MF increases, in the epidermis and dermis
both peaked at 295 nm and showed parallel and nearly
identical kinetics of exponential decreases at wavelengths
longer than 300 nm, with a constant 2–3-fold higher muta-
genicity in the epidermis (Figure 1b). The differences at
wavelengths shorter than 300 nm would be attributable to
the poor penetration of this range of UVR into the skin (Bruls
et al., 1984; Young et al., 1998). The reciprocals of MMISD
and MID were used as indices of the action spectra of MIS and
inflammation inductions, respectively (Figure 1a). The result-
ing values at each wavelength for the two spectra were quite
similar to each other except at wavelengths shorter than
295 nm (Figure 1c and Supplementary Table S2 online).
All the action spectra defined here were normalized to 1 at
307 nm (Supplementary Table S2 online) and compared with
one another along with the two previously published action
spectra in human skin: one for cyclobutane pyrimidine dimer
(CPD) formation (Freeman et al., 1989) and the other for
erythema induction, for which two erythema spectra were
combined here (Parrish et al., 1982; Anders et al., 1995)
(Figure 1d). Although the erythema action spectrum recom-
mended by the International Commission on Illumination (CIE)
(McKinlay and Diffey, 1987) has been widely used for UVR
risk assessments, the CIE spectrum has the drawback of a
shallower decline in the 300–320-nm region than Anders’s
because of the use of monochromatic UVR sources with wider
half-power bandwidths in this wavelength region. Owing to
the normalization, all the spectra showed relatively similar
kinetics in the range of 300–325 nm, though they diverged
outside of this range. The spectra of inflammation (edema) in
mice and erythema in human showed a strong resemblance to
each other, supporting a common vascular mechanism for
these symptoms, as suggested previously (Cole et al., 1983).
The MIS spectrum also shared nearly identical kinetics with
these two spectra except at wavelengths shorter than 300 nm,
suggesting a mechanistic link between MIS and inflammation/
erythema. This link is further supported by the fact that the
actual values of MMISD and MID were similar (Figure 1c and
Supplementary Table S2 online), as were the minimum UVR
doses necessary to induce human erythema and mouse
inflammation (edema) (Cole et al., 1983). On the other
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hand, the mutagenicity spectra in the epidermis and dermis
were relatively similar to the CPD action spectrum in human
skin (Freeman et al., 1989). Another CPD action spectrum in
human skin (Young et al., 1998) was as similar to our
mutagenicity spectra as Freeman’s and further showed a
shielding effect of the epidermal layer on CPD formation at
wavelengths less than 300 nm, which corresponds to the
enhanced lowering of the mutagenicity in the dermis than in
the epidermis at wavelengths less than 295 nm in our analysis
with mice (Figure 1d). These similarities are consistent with
the molecular mechanism underlying UVR mutagenesis, in
which CPDs are known to have a major role (You et al.,
2001). In contrast, the difference between these two groups
in the action spectra of CPD formation/mutagenicity and
MIS/inflammation/erythema was noteworthy. These two
groups diverged largely at wavelengths longer than 325 nm,
suggesting a different mechanistic origin of MIS/erythema from
that of UVR mutagenesis.
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Figure 1. Wavelength dependence of UVR genotoxicity in the skin. (a) Representative dose-dependent mutation induction kinetics in mouse skin. The indicators
used for estimation of the UVR biological effects on the skin (mutagenicity, MIS, and inflammation) are illustrated using the dose–response plot of induced MFs at
300 nm. The indices of these indicators used for the generation of action spectra are given on the right. (b) Action spectra of mutagenicity in the epidermis (red) and
dermis (cyan). Statistically nonsignificant points (see Supplementary Table S1 online) are plotted with broken lines. Error bars indicate SE. (c) Action spectra of
inflammation (green circles) and MIS (blue open circles). Error bars in the MIS spectrum represent SD. (d) Comparison of the action spectra of mutagenicity,
inflammation, and MIS (symbols are the same as those in b and c) with two action spectra in human skin of cyclobutane pyrimidine dimer (CPD) formation (black
broken line) (Freeman et al., 1989) and erythema (violet triangles) (Parrish et al., 1982; Anders et al., 1995). Each spectrum is normalized at 307 nm for
comparison. (e) Wavelength-dependent change of the plateau MF (blue) and MID-induced MF (red). In the plateau MF plot, error bars represent SD, and the
tentative value at 334 nm (cyan) is plotted with broken lines.
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Wavelength dependence of the plateau MF and MID-induced MF
The most remarkable finding in the present study was that the
MF plateau observed in the MIS response was wavelength
dependent, showing a peak at around 310–320 nm, maximally
18-fold higher than at the other wavelengths (blue line,
Figure 1e). At wavelengths shorter than 290 nm and longer
than 334 nm, the plateau MF was strongly suppressed to levels
only 2–3-fold higher than the background MF in unirradiated
epidermis, whereas it was elevated at wavelengths between
290 and 330 nm and peaked at a level 40-fold higher than the
background at around 315 nm, the border wavelength of UVA
and UVB, indicating that the MIS attenuated greatly at around
the border wavelength. As the MF plateau shows the limit of
mutation loads inducible at each wavelength by a single dose
of irradiation, this finding suggests that shorter, hence, more
mutagenic and erythematic wavelengths of UVR do not
always cause more mutations in the epidermis. The mid-range
wavelengths around the UVA–UVB border, whose genotoxi-
city has been poorly evaluated, could bring much higher
mutation loads to the skin genome, which may explain our
earlier observation that the sun induced mutations in the skin
at much higher frequencies than UVB lamps that more
effectively emit the shorter wavelengths of sunlight UVR
(Ikehata et al., 2004).
As shown above, the action spectra of MIS and inflamma-
tion were quite similar to each other, which reflected the
similarity between MMISD and MID. As the plateau MF is
equivalent to the MMISD-induced MF, the wavelength depen-
dence of MID-induced MF might be similar to that of the
plateau MF. This was the case as shown in Figure 1e (red line).
Both the wavelength dependencies increased identically up to
313 nm and beyond that decreased similarly with only a small
difference with relatively lower values for the MID-induced
MF. The 313-nm peak value of MID-induced MF was 39-fold
higher than the lowest value at 364 nm (1.1910 4). This
observation indicates that inflammation does not always
reflect the genotoxicity to the skin brought by UVR, and
suggests that erythema-based UVR risk assessments may be
unreliable for evaluating the UVR genotoxicity.
DISCUSSION
In previous action spectrum studies on UVR genotoxicity in
skin, the efficiencies of DNA photolesion formation and skin
cancer induction coincidently peaked at around 295 nm
(Freeman et al., 1989; de Gruijl et al., 1993), consistent with
our action spectra of mutagenicity (Figure 1b). This close
correspondence supports a mechanistic link among damage
formation, mutagenesis, and carcinogenesis in the skin, which
had already been suggested in many studies. However, the
remarkably high mutation induction after solar UVR exposure
and the relatively inefficient mutation induction by UVB
lamps we observed in our earlier studies (Ikehata and Ono,
2002; Ikehata et al., 2004) cannot be explained by these
action spectra alone. The MIS response established in
the present study would provide such an explanation and
enable us to estimate UVR genotoxicity for the skin more
appropriately. The wavelength dependence of the plateau MF
(Figure 1e) indicates that the MIS response is reduced in
the UVA–UVB border region, where the solar UVR output
reaches the earth’s surface with poor attenuation through the
stratospheric ozone layer. The reduction in the MIS response
would have resulted in the high mutation load in the skin
observed after only 30-min exposure to noon sunlight in
summer (Ikehata et al., 2004), which was as high as the
plateau MF peak in Figure 1e. Conversely, the response should
occur potently at wavelengths shorter than those of the border
region and suppress mutations to low plateau MFs, as
observed with the UVB lamps (Ikehata and Ono, 2002).
Thus, the MIS response can suppress mutagenesis in skin
exposed to genotoxic agents. As MIS equivalent responses
have not been reported in cultured cells, MIS seems to be a
tissue-specific response by which multicellular organisms
protect themselves from environmental genotoxic insults.
MIS might also prevent the genotoxicity of various agents in
various tissues. It is known that some agents that induce
mutations in cultured cells show poor mutagenicity in tissues
(Heddle et al., 2000; Thilly, 2003; Lambert et al., 2005),
which may also be explained by the MIS response. However,
the leveling-off response in mutation induction with MIS
seems similar to the dose–response kinetics of mutant yield
(MY), in which a plateau is also observed, although MY rather
decreases as the dose increases further (Haynes et al., 1985).
The MIS response should not be confused with the MY
kinetics because MF (mutants/survivors) and MY (mutants/
treated population) are different quantities. MF usually
increases linearly or linear-quadratically with the dose
(Haynes et al., 1985), which should be the case even in
tissues such as skin. Thus, the MF leveling off is an unusual
and remarkable observation. In addition, the MF plateau
observed in MIS is not the result of a saturation in mutations
in the epidermal cell population, as already demonstrated in
our previous study, in which the dose-dependent MF increase
reappeared by delivering a MIS-inducible UVR dose in
fractions at sufficient intervals (Ikehata and Ono, 2002). As
the plateau appears over a certain, high UVR dose, it is also
possible that the repetitive structure of the transgenes in the
mouse genome is made unstable by the UVR insult, leading to
the MF plateau. High doses of UVR could induce a large
amount of DNA damage, which would cause replication fork
arrest and might result in the loss of repetitive sequence units,
namely the phage vector–lacZ transgene construct, resulting in
a low recovery of the transgenes. In this case, however, not
only mutant transgenes but also unaffected non-mutant ones
should have been equally lost from the genome so that the
dose-dependent increases in MF (mutants/sum of non-mutants
and mutants) might not have been influenced. In fact, there
were no substantial reductions in the lacZ recovery from the
epidermis even after UVR exposures higher than MMISD.
Another possible cause of the plateau in MFs is the selective
inactivation of vector recovery for the vector–transgene con-
structs that suffer DNA damage at more than the threshold
amount that causes the MIS response. Such inactivation could
be accomplished by a selective deletion of heavily damaged
vector–transgene constructs without affecting neighboring
less-damaged constructs. However, it is difficult to envision
an underlying enzymatic mechanism for such selective
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deletions based on the knowledge available so far. Instead of
the selective deletion of heavily damaged transgene con-
structs, a selective elimination of heavily damaged epidermal
cells would be more probable.
With regard to the mechanism of the MIS response, we
have proposed a model (Ikehata et al., 2010) in which massive
apoptosis selectively eliminates heavily damaged cells in
the affected tissue, followed by hyperplasia that renews the
tissue with active propagation and repopulation of less-
damaged surviving cells, by which the extent of genotoxic
damage received determines the level of the plateau MF, thus
resulting in the suppression of mutation induction. The
surviving cell population should reside deep in the skin,
e.g., in the basal layer or hair follicles, where they would be
exposed to less UVR than the upper cell population because
UVR is attenuated as it penetrates the skin tissue. This model
was derived from our 72-h observation of apoptosis induction,
which was monitored with caspase-3 activation, and
hyperplasia in the skin after exposure to a UVB dose larger
than the MMISD (Ikehata et al., 2010), and supported by the
similarity between the MIS and inflammation spectra
demonstrated in the current study because high-dose UVR-
induced apoptosis and hyperplasia are often associated with
inflammation (Caricchio et al., 2003; Tsaalbi-Shtylik et al.,
2009). Thus, the MIS response would exert its antigenotoxicity
at the cost of killing cells, which suggests that MIS is also a
destructive response for damaged tissues. On the basis of this
mechanistic model for MIS, the wavelength dependence of the
plateau MF could be explained as the result of a convolution
of two opposing processes of MIS and mutagenesis because
the plateau MFs are the product of mutagenicity and MMISD.
The difference between the MIS and mutagenicity action
spectra demonstrated in the present study must have resulted
in the peak of the plateau MF at the UVA–UVB border region
(Figure 1e). The difference in the action spectra may reflect a
difference in the contributing chromophores or photochemical
products between MIS and mutagenesis. As CPD is known to
be a major mutagenic photolesion induced widely at wave-
lengths ranging from UVC to UVA (You et al., 2001; Ikehata
and Ono, 2011), this photolesion would likely contribute to
the mutagenicity spectrum. The DNA damage or signaling
molecules responsible for the MIS response would be different
from CPD.
On the other hand, MIS was not observed in the dermis.
This would result partly from the difference in the cell type,
namely, the difference between fibroblasts and keratinocytes,
whose responsiveness to genotoxic insults might be different
(D’Errico et al., 2007). Another possibility is that the genotoxic
damage given to the dermis was not sufficient to induce a MIS
response, as evidenced by the observation that the MFs
induced in the dermis did not go over the plateau MFs,
except for those induced at 364 nm (see Supplementary Figure
S1 online). In the wavelength range of 300–313 nm, the MFs
in the dermis seemed to be saturated at the level of the
epidermal MF plateaus. Although some apoptotic cells were
actually observed in the dermis after UVB exposure, they were
too rare to analyze quantitatively (Ikehata et al., 2010).
However, in the dose ranges where the dermal MF was
close to the epidermal plateau, the skin showed serious
tissue damage such as ulceration, resulting in such a tissue
loss that the MIS response could not appear in the dermis.
In the current study, MIS showed a similar action spectrum
to those of skin inflammation in mice and erythema in human
in the wavelength region of solar UVR (Figure 1d). As
mentioned above, MIS seems to be an antigenotoxic but
destructive response to UVR-damaged tissue. If a UVR dose to
the skin is too high, the MIS response could backfire,
subjecting the affected tissue to the risk of inflammatory
destruction such as burn and ulceration because of the
inability to reconstruct sufficiently the destroyed tissue from
less-damaged surviving cells, few of which would remain.
Actually, after exposure of the mice to UVR doses much
higher than MMISD, we observed serious skin tissue damage
such as ulceration following severe inflammation, such as
reddening and edema, in the exposed skin area. Generally,
people experience sunburn (erythema) and skin peeling
(desquamation) multiple times during a lifetime after exposure
to too much sunlight in summer, the dose of which usually
exceeds the minimum erythema dose (MED). The similarity
between the action spectra of MIS and inflammation/
erythema, more specifically, the similarity between MMISD
and MID/MED, suggests that erythema could serve as a
warning against overexposure to UVR that would cause an
unnecessarily potent induction of the antigenotoxic but
destructive MIS response, which could result in harmful acute
skin damage. In other words, erythema can indicate that the
affected skin tissue is under construction after the MIS
destructive response, and caution us not to disturb it.
MED has been widely used as an index for UVR risk
assessment for the skin and as a measure for the dose control
of dermatological phototherapies (Parrish and Jaenicke, 1981;
Parrish et al., 1982; McKinlay and Diffey, 1987). However,
the wavelength dependence of the MID-induced MF
(Figure 1e), which peaks at the UVA–UVB border wave-
lengths, means that MID/MED-regulated dose regimens cannot
effectively prevent mutation induction by such border wave-
lengths and that inflammation/erythema-based estimations
overlook the risk of the resulting high mutation loads. More
specifically, the wavelength dependence tells us that avoiding
inflammation/erythema does not always prevent genotoxicity,
but the appearance of a plateau MF after the MIS response
teaches us that exposure to a dose over MID/MED does not
always lead to a higher genotoxicity than that induced by
MID/MED. Thus, evaluations based on erythema alone are not
appropriate for UVR risk assessment for skin genotoxicity.
In the present study, we characterized MIS more precisely
using action spectrum analysis than in any previous study of
ours (Ikehata and Ono, 2002; Ikehata et al., 2004, 2008), and
generalized it as a phenomenon that can occur in the mouse
skin epidermis in a wide wavelength range of UVC–UVA. MIS
would reflect a tissue-specific protective response of mammals
to UVR genotoxicity, which cannot be revealed in studies of
single-cell organisms such as bacteria and cultured cells. The
combined use of the action spectra of MIS and mutagenicity
would be a powerful tool for the assessment of UVR
genotoxicity in the skin. However, extrapolation to human
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skin of the results from mouse skin would require taking some
considerations into account. As human and mouse are both
mammals and evolutionarily quite close, their skin structures
and skin-relevant genetic configurations are largely identical,
which justifies the use of mice as a model of human skin.
Nevertheless, some differences in the skin structure between
the two species might influence the action spectra analyzed
here. Those differences would include the presence or
absence of hair coat, the position in the skin layers of
melanocytes, and the thickness of the constituent layers. The
former two influences could be excluded from the analysis by
using hairless or depilated mice and by using albino mice or
mice in the resting phase of the hair cycle, whose skin is
apparently equivalent to human fair skin. However, differ-
ences in the layer thickness would remain influential and,
especially, the epidermal thickness would be most influential
because UVR is easily attenuated at wavelengths shorter than
300 nm when penetrating thorough the epidermis (Bruls et al.,
1984). Mouse epidermis is quite thin, usually consisting of one
or two basal cell layers with a well-differentiated cornified
layer on top of them, whereas human epidermis is much
thicker, comprising several cell layers that are gradually
differentiated from the basal cell layer to the surface stratum
corneum. The attenuating effect of the epidermis was evident
even in the mutagenicity spectra of mice, as shown in the
present study (Figure 1d), in which the mutagenicity in the
dermis was diminished more drastically than in the epidermis
at wavelengths shorter than 300 nm. In human skin, this
attenuating effect is much more remarkable, as shown in the
same graph: the efficiency of CPD formation in human skin
decreased as drastically as the mutagenicity in mouse dermis
at the shorter wavelengths, even though the analysis in human
was of the epidermal layer (Freeman et al., 1989). Actually,
the attenuating effect depends on the epidermal depth, as
reported previously (Young et al., 1998). Hence, this effect of
the epidermal thickness should be taken into consideration to
appropriately adjust the mouse data to fit human skin. Trials of
such adjustment have already been reported before (Tyrell and
Pidoux, 1987; de Gruijl and van der Leun, 1994). Thus, as far
as these considerations are properly taken into account,
application of the mouse action spectra developed here to
UVR genotoxicity estimations in human skin would be highly
feasible and useful for the prediction and prevention of UVR-
induced human skin cancers.
MATERIALS AND METHODS
Mice and monochromatic UVR irradiation
All animal studies were conducted according to the Guidelines for
Animal Welfare and Experimentation at Tohoku University and the
National Institutes of Natural Sciences. A transgenic mouse strain
harboring l-phage-based lacZ mutational reporter genes (Gossen
et al., 1989) was used. Two or more 8–12-week-old mice depilated
on the back 3 days before were exposed under anesthesia to each
dose of monochromatic UVR at each wavelength through an
appropriate filter to cut off stray light of shorter wavelengths. The
monochromatic UVR sources used were a laser for 364 nm, which
can irradiate a wide field at high intensities (Ikehata et al., 2008), and
a huge monochromator, the Okazaki Large Spectrograph (Watanabe
et al., 1982), for the other wavelengths, both of which were available
at the National Institute for Basic Biology, Japan. The spectral
bandwidth of the exposure fields we used for the mouse exposure
with the monochromator was 4 nm, with its center at the wavelength
points for which the analyses of the dose–response kinetics were
performed, so that there was a 4-nm difference between both ends of
an exposed region of skin (about 5-cm long in the skin). The spectral
half-power bandwidths of the monochromator were ±2.7 nm at all
wavelengths. For the 364-nm laser, it was ±1 nm. Dosimetry was
performed with a silicone photodiode (Hamamatsu Photonics,
Hamamatsu, Japan), which had been calibrated with a National
Institute of Standards and Technology standard by the manufacturer.
The irradiances at 260–295 nm were calibrated to B0.1–6 W m 2
using neutral density quartz filters with exposure times adjusted
within 10 seconds–3 minutes, and those at 300 nm were B 6 and
25 W m 2 with exposure times less than 3 minutes. The irradiances
used at 307, 313, 319, 325, 330, and 334 nm were B10–30 W m 2
with exposure times less than 6, 30, 130, 310, 770, and 570 minutes,
respectively, and that at 364 nm was B300 W m 2 with exposure
times of 25–155 minutes.
Inflammation and mutation assays
The appearance of inflammation on the exposed areas, manifested as
edema and subsequent reddening and desquamation of the skin, was
inspected macroscopically during the 1–4 days after irradiation. Four
weeks after irradiation, a time sufficient to express mutations in the
skin (Ikehata and Ono, 2002) and to recover the tissue (Ikehata et al.,
2010), the exposed skin areas were depilated again and sampled for
mutation analysis, which was performed as previously described
(Ikehata et al., 2003). Briefly, the whole irradiated area of skin was
excised and separated into the epidermis and dermis, from each of
which total genomic DNA was extracted. The lacZ transgenes in the
DNA were recovered as phage particles by in vitro packaging and
transferred into bacterial cells that were defective in both the lacZ and
galE genes. Using the P-gal-positive selection method, lacZ mutant
phages were detected as plaques on a bacterial lawn. The number of
plaques was scored and used to calculate MF.
Evaluation of plateau MFs and the indices for action spectra
Initial slopes of the MF increase (J 1 m2), which were used as an
index for mutagenicity, in the epidermis and dermis were determined
with regression analysis at each wavelength examined in the dose
range shown in Supplementary Table S1 online. Plateau MFs were
determined by averaging the epidermal MF values observed in the
dose range shown in the same table, where the MF level was
regarded as in the MIS mode. Minimum MIS dose (MMISD, J m 2)
was calculated by dividing the plateau MF by the initial slope of the
epidermal MF increase at the same wavelength. The lowest UVR dose
that induced inflammation for almost all exposed animals was scored
as the MID (J m 2).
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